
Nucleic Acid Nanotheranostics
Biomedical Applications
Description
Key Features
- Provides a unique source of knowledge (theoretical as well as practical) on nanotheranostic materials for gene therapy at all levels and related scientific areas
- Covers the pros and cons related to viral and nanomaterial-based delivery of nucleic acids in terms of biosafety, carrier selection, synthesis and bioimaging
- Presents the only book to include an analysis of nanoformulations approved for clinical use
Readership
Materials Scientists and Biochemists, Biomedical engineers, Clinicians, Pharmaceutical chemists, and researchers working on nanomaterials, especially those with healthcare applications
Table of Contents
1. Therapeutic oligonucleotides against cancer: Recent approaches and new perspectives
2. Small interfering RNA-mediated silencing of ribophorin II (RPN2) gene: The way forward for the treatment of malignant breast cancer
3. Non-coding RNAs in cardiovascular disease
4 MicroRNAs in respiratory diseases
5. State of the art and future direction for the analysis of cell-free circulating DNA
6. Aptamer-based strategies for diagnosis
7. Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges
8. Nonviral nucleic acid therapy: Peptiplexes
9. Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
10. Advanced Polymers for Nonviral Gene Delivery
11. Nonviral Gene Therapy: Design and Application of Inorganic Nanoplexes
12. Extracellular vesicles as a novel nanocarriers for therapeutic delivery
13. Nanocarrier-based Gene therapy Imaging Strategies
14. The state-of-art of investigational and approved nanomedicine products for nucleic acid delivery
Product details
- No. of pages: 491
- Language: English
- Copyright: © Elsevier 2019
- Published: February 26, 2019
- Imprint: Elsevier
- eBook ISBN: 9780128144718
- Paperback ISBN: 9780128144701